Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Engelholm

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Ugeskrift for Laeger|January 14, 1991
[Treatment of cervix cancer in Denmark]A K Jakobsen, K Bertelsen, B Andreasson, et al.
European Urology|October 24, 2003
Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary GroupG O N Oosterhof, J T Roberts, Th M de Reijke, et al.
Acta Radiologica. Oncology|January 1, 1984
Testicular carcinoma in Denmark 1976-1980. Stage and selected clinical parameters at presentationH P Schultz, J Arends, H Barlebo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancerJ P Neijt, S A Engelholm, M K Tuxen, et al.
British Journal of Cancer|July 1, 2010
A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumoursU Lassen, L R Molife, M Sorensen, et al.
Seminars in Oncology|November 5, 1997
Paclitaxel (175 mg/m2 over 3 hours) with cisplatin or carboplatin in previously untreated ovarian cancer: an interim analysisJ P Neijt, S A Engelholm, P O Witteveen, et al.
Ugeskrift for Laeger|May 26, 1997
[Patients with early stages of endometrial cancer should be spared adjuvant radiotherapy. Danish Endometrial Cancer Group]H K Poulsen, M Jacobsen, K Bertelsen, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Ugeskrift for Laeger|January 14, 1991
[Treatment of cervix cancer in Denmark]A K Jakobsen, K Bertelsen, B Andreasson, et al.
European Urology|October 24, 2003
Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary GroupG O N Oosterhof, J T Roberts, Th M de Reijke, et al.
Acta Radiologica. Oncology|January 1, 1984
Testicular carcinoma in Denmark 1976-1980. Stage and selected clinical parameters at presentationH P Schultz, J Arends, H Barlebo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancerJ P Neijt, S A Engelholm, M K Tuxen, et al.
British Journal of Cancer|July 1, 2010
A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumoursU Lassen, L R Molife, M Sorensen, et al.
Seminars in Oncology|November 5, 1997
Paclitaxel (175 mg/m2 over 3 hours) with cisplatin or carboplatin in previously untreated ovarian cancer: an interim analysisJ P Neijt, S A Engelholm, P O Witteveen, et al.
Ugeskrift for Laeger|May 26, 1997
[Patients with early stages of endometrial cancer should be spared adjuvant radiotherapy. Danish Endometrial Cancer Group]H K Poulsen, M Jacobsen, K Bertelsen, et al.
Pageof 6